首页> 外国专利> HEAT SHOCK RNA AND ITS USE IN ACTIVATION OF HEAT SHOCK TRANSCRIPTION FACTOR AND TREATMENT OF CANCER, INFLAMMATION, ISCHEMIA, NEURODEGENERATION, AGE-RELATED DISEASES, HIV INFECTION, DEAFNESS, AND RELATED DISORDERS

HEAT SHOCK RNA AND ITS USE IN ACTIVATION OF HEAT SHOCK TRANSCRIPTION FACTOR AND TREATMENT OF CANCER, INFLAMMATION, ISCHEMIA, NEURODEGENERATION, AGE-RELATED DISEASES, HIV INFECTION, DEAFNESS, AND RELATED DISORDERS

机译:热休克RNA及其在热休克转录因子激活和癌症,炎症,局部缺血,神经衰老,年龄相关疾病,HIV感染,聋哑和相关疾病的治疗中的用途

摘要

The present invention provides a novel RNA, designated herein as the “HSR1” (Heat Shock RNA), and its use together with translation elongation factor eEF1A in activation of heat shock transcription factor HSF. The invention further provides the use of HSR1 for generation of novel therapeutics for the treatment of cancer, inflammation, ischemia, neurodegeneration, age-related diseases, HIV infection, deafness, and related disorders.
机译:本发明提供了新颖的RNA,在本文中称为“ HSR1”​​(热休克RNA),并将其与翻译延伸因子eEF1A一起用于热休克转录因子HSF的活化中。本发明进一步提供了HSR1在产生用于治疗癌症,炎症,局部缺血,神经退行性疾病,年龄相关疾病,HIV感染,耳聋和相关疾病的新型疗法中的用途。

著录项

  • 公开/公告号US2007238682A1

    专利类型

  • 公开/公告日2007-10-11

    原文格式PDF

  • 申请/专利权人 EVGENY A. NUDLER;ILYA SHAMOVSKY;

    申请/专利号US20060612156

  • 发明设计人 ILYA SHAMOVSKY;EVGENY A. NUDLER;

    申请日2006-12-18

  • 分类号A61K31/7052;C12N15/00;C12N15/11;C12N5/10;C12Q1/68;

  • 国家 US

  • 入库时间 2022-08-21 21:07:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号